We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
NK Cell-Based Immunotherapy in Colorectal Cancer.
- Authors
Della Chiesa, Mariella; Setti, Chiara; Giordano, Chiara; Obino, Valentina; Greppi, Marco; Pesce, Silvia; Marcenaro, Emanuela; Rutigliani, Mariangela; Provinciali, Nicoletta; Paleari, Laura; DeCensi, Andrea; Sivori, Simona; Carlomagno, Simona
- Abstract
Human Natural Killer (NK) cells are all round players in immunity thanks to their powerful and immediate response against transformed cells and the ability to modulate the subsequent adaptive immune response. The potential of immunotherapies based on NK cell involvement has been initially revealed in the hematological setting but has inspired the design of different immune tools to also be applied against solid tumors, including colorectal cancer (CRC). Indeed, despite cancer prevention screening plans, surgery, and chemotherapy strategies, CRC is one of the most widespread cancers and with the highest mortality rate. Therefore, further efficient and complementary immune-based therapies are in urgent need. In this review, we gathered the most recent advances in NK cell-based immunotherapies aimed at fighting CRC, in particular, the use of monoclonal antibodies targeting tumor-associated antigens (TAAs), immune checkpoint blockade, and adoptive NK cell therapy, including NK cells modified with chimeric antigen receptor (CAR-NK).
- Subjects
IMMUNOTHERAPY; COLORECTAL cancer; KILLER cells; IMMUNE checkpoint proteins; CHIMERIC antigen receptors; IMMUNE response
- Publication
Vaccines, 2022, Vol 10, Issue 7, pN.PAG
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines10071033